Human RNase H1 mutants
AssigneeIsis Pharmaceuticals, Inc.
InventorsHongjiang Wu, Walter F. Lima, Stanley T. Crooke
Life of this patent
Estimating the term…
Abstract
A human RNase H polypeptide and methods of use are provided.
Claims5
A human RNase H1 polypeptide which comprises a mutation compared to wild type human RNase H1, wherein said mutation produces a mutant version of human RNase H1 polypeptide that consists of a deletion mutation of region I, a deletion mutation of region II, a deletion mutation of region I and region II, or a lysine-to-alanine substitution at amino acids 226 and 227 of SEQ ID NO:
- 3, and wherein said mutant version retains detectable cleavage activity for the RNA strand of an RNA/DNA duplex.
A human H1 polypeptide which consists solely of the basic substrate binding domain which consists of region III and which retains detectable cleavage activity for the RNA strand of an RNA/DNA duplex.
Dependencies are inferred from the claim text.